Concerto Biosciences

Concerto examines microbial interactions with unmatched experimental depth to discover breakthrough microbe-based products. Their foundational platform, kChip, was invented by the cofounders while at MIT and the Broad Institute and is a discovery engine that physically constructs millions of miniature, defined microbial communities simultaneously. By observing the behavior of each community, Concerto can rapidly identify the most promising microbes, prebiotics, and postbiotics for development into new products. In partnership with a diverse array of biotech and pharma companies, Concerto aims to unleash a new era of microbial research and microbe-based products.